
|Articles|December 15, 2016
December Peer Appendix
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Peptide Compounding Vote Raises New Questions for Drug Developers
3
Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates
4
PharmTech Weekly Roundup—July 17, 2026
5




